B
BioCryst Pharmaceuticals, Inc. (BCRX)
NMS – Real vaqt narxi. Valyuta: USD
10.36
+0.02 (0.19%)
Bozor ochiq: Aug 12, 2026, 11:54 AM EDT
10.23
-0.11 (-1.06%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
10.36
+0.02 (0.19%)
Bozor ochiq: Aug 12, 2026, 11:54 AM EDT
10.23
-0.11 (-1.06%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
This stock has a consensus price target of $20.93 based on the ratings of 15 analysts. The high is $32.00 and the low is $9.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 9 | $ 20.93 | $ 32 |
| O’zgarish | -12.96% | 102.42% | 209.48% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-07-13 | 16.05% | JP Morgan | $12 | Reinstates | Neutral |
| 2026-07-07 | 35.4% | RBC Capital | $13 → $14 | Maintains | Outperform |
| 2026-06-30 | 209.48% | HC Wainwright & Co. | $32 → $32 | Maintains | Buy |
| 2026-06-30 | 180.46% | Cantor Fitzgerald | $27 → $29 | Maintains | Overweight |
| 2026-05-07 | 170.79% | Citizens | $25 → $28 | Maintains | Market Outperform |